Hospital Based Registry of Childhood Cancer in Pediatric Oncology Units in French Speaking Africa (RFAOP)

September 11, 2023 updated by: French Africa Pediatric Oncology Group

French African Pediatric Oncology Registry

The ultimate aim of this registry is to collect precise information concerning the children coming to oncology units working with the French African Oncology Group. This data will help to plan and provide correct pediatric oncology treatment and care for this population.

Collecting the data will give much needed information on numbers, stage, treatment and outcome. The register will give data for local and national health authorities in planning pediatric cancer programs.

Study Overview

Status

Recruiting

Conditions

Detailed Description

This register is a registration of all children entering hospital based pediatric oncology units, working in selected hospitals in French speaking Africa. The data collected includes: demographic and socioeconomic status as well as clinical status and outcome.

The register also collects information on vital status, treatment abandonment and loss to follow-up.

Data, collected locally is entered on line using the Research Electronic Data Capture (REDCap) program. Data are stored under the responsibility of the IT department at Gustave ROUSSY in Paris- Villejuif.

Study Type

Observational

Enrollment (Estimated)

10000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

  • Burkina Faso
      • Ouagadougou, Burkina Faso, 03 BP 7022
        • Recruiting
        • Hopital Yalgado Ouedraogo
        • Contact:
          • BOUDA CHANTAL, DR
      • Ouagadougou, Burkina Faso
        • Recruiting
        • Centre Hospitalier Universitaire Pédiatrique Charles De Gaulle
        • Contact:
          • Sonia Ms Kaboret, Dr
        • Contact:
          • kawajo200046@gmail.com
  • Cameroon
      • Yaoundé, Cameroon
        • Recruiting
        • Centre Mère et Enfant CME-FCB (Fondation Chantal Biya)
        • Contact:
  • Congo, The Democratic Republic of the
      • Kinshasa, Congo, The Democratic Republic of the, BP 12 KIN XI
        • Recruiting
        • Cliniques Universitaires de Kinshasa
        • Contact:
          • BUDIONGO Aléine, DR
      • Lubumbashi, Congo, The Democratic Republic of the, BP 1825
        • Recruiting
        • Cliniques Universitaires de Lubumbashi (CUL)
        • Contact:
  • Côte D'Ivoire
      • Abidjan, Côte D'Ivoire
        • Recruiting
        • CHU de Treichville à ABIDJAN
        • Contact:
          • Line Guei COUITCHERE, MD
  • France
  • Gabon
      • Libreville, Gabon
        • Recruiting
        • l'Institut de Cancérologie de Libreville
        • Contact:
          • Betty NDAKISSA, DR
  • Madagascar
    • Ampefiloha
      • Antananarivo, Ampefiloha, Madagascar, BP 4150
        • Recruiting
        • HJRA, Hôpital universitaire Joseph Ravoahangy Andrianavalona
        • Contact:
  • Mali
      • Bamako, Mali
        • Recruiting
        • CHU Gabriel Touré (HGT)
        • Contact:
  • Mauritania
      • Nouakchott, Mauritania
        • Recruiting
        • Centre National d'Oncologie (CNO)
        • Contact:
          • Ekhtel Benina ZEIN, DR
          • Phone Number: 222 45 24 22 32
  • Niger
      • Niamey, Niger
        • Recruiting
        • CNLC, Centre National de Lutte contre le Cancer
        • Contact:
          • Aichatou MAHAMADOU, DR
  • Senegal
      • Dakar, Senegal
        • Recruiting
        • Hôpital Aristide Le Dantec, Avenue Pasteur, BP 3001
        • Contact:
  • Togo
      • Lomé, Togo, BP 57
        • Recruiting
        • CHU Sylvanus Olympio
        • Contact:
          • Koffi Mawuse Jules GUEDENON, DR

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 day to 18 years (Child, Adult)

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

All childre with any pediatric cancer types, coming into any one of the participating units in a 12 month period.

Description

Inclusion Criteria:

  1. Any child presenting at any one of the participating units for treatment
  2. Any child with any type of cancer
  3. Any child or adolescent less than 18 years of age.

Exclusion Criteria:

  1. No cancer found
  2. Age greater than 18 years -

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of children with a suspicion of any type of cancer in a given unit
Time Frame: in any 12 month period

Number of children with details of :

  1. the type of cancer
  2. the stage of the identified cancer coming into a given unit
in any 12 month period
VITAL STATUS:
Time Frame: in any 12 month period

Dead or alive

  1. The number of children living
  2. the number of children dead
in any 12 month period
Illness status
Time Frame: in any 12 month period
  1. The number of children relapsed,
  2. The number of children whos illness has progressed.
in any 12 month period
Treatment Status
Time Frame: in any 12 month period
  1. The number of children who had treatment administered,
  2. The number of children who abandoned treatment
in any 12 month period

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

French Africa Pediatric Oncology Group

Collaborators

Gustave Roussy, Cancer Campus, Grand Paris

Investigators

  • Study Director: Brenda Mallon, MSc, French Africa Pediatric Oncology Group

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2016

Primary Completion (Estimated)

December 1, 2025

Study Completion (Estimated)

December 1, 2030

Study Registration Dates

First Submitted

November 8, 2018

First Submitted That Met QC Criteria

January 14, 2019

First Posted (Actual)

January 15, 2019

Study Record Updates

Last Update Posted (Actual)

September 13, 2023

Last Update Submitted That Met QC Criteria

September 11, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • GFAOP

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

Units have acess to their own data and can use it for reporting.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pediatric Cancer

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Norway

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe